Profile
Georg Buchner worked as a Vice President in Business Development at Silence Therapeutics Plc from 2011 to 2012.
Prior to that, he held the same position at PolyTherics Ltd.
and Novacta Biosystems Ltd.
He was also a Manager of Business Development at PharmaVentures Ltd.
in 2013.
Before his career in business, he earned a doctorate from King's College London and an MBA from the University of Cambridge.
Former positions of Georg Buchner
| Companies | Position | End |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Corporate Officer/Principal | 31/05/2012 |
PharmaVentures Ltd.
 PharmaVentures Ltd. Investment ManagersFinance Pharma Ventures Ltd. provides advisory services on life sciences transactions. It offers mergers and acquisitions, licensing, strategy and valuation, and expert services. The firm's industry coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. The company is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
PolyTherics Ltd.
 PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom. | Corporate Officer/Principal | - |
Haptogen Ltd.
 Haptogen Ltd. Pharmaceuticals: MajorHealth Technology Haptogen Ltd. manufactures biopharmaceuticals products. The company was founded by Jim Reid in 2002 and is headquartered in Aberdeen, UK. | Corporate Officer/Principal | - |
Novacta Biosystems Ltd.
 Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Training of Georg Buchner
| University of Cambridge | Masters Business Admin |
| King's College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Private companies | 4 |
|---|---|
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Health Technology |
Haptogen Ltd.
Haptogen Ltd. Pharmaceuticals: MajorHealth Technology Haptogen Ltd. manufactures biopharmaceuticals products. The company was founded by Jim Reid in 2002 and is headquartered in Aberdeen, UK. | Health Technology |
PolyTherics Ltd.
PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom. | Health Technology |
PharmaVentures Ltd.
PharmaVentures Ltd. Investment ManagersFinance Pharma Ventures Ltd. provides advisory services on life sciences transactions. It offers mergers and acquisitions, licensing, strategy and valuation, and expert services. The firm's industry coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. The company is headquartered in Oxford, the United Kingdom. | Finance |
- Stock Market
- Insiders
- Georg Buchner